Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bangkok Dusit Medical Services PCLBDULF 68 Return-on-Tangible-Asset is 11.55% as of Mar. 2026, which is 7% above its 10-year median of 10.77. GuruFocus rates BDULF with a GF Score™ of 68/100 and a GF Value™ of $0.83 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 84.83% on this metric.
The historical rank and industry rank for Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset or its related term are showing as below:
BDULF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.25 Med: 10.77 Max: 13.64
Current: 11.5
During the past 13 years, Bangkok Dusit Medical Services PCL's highest Return-on-Tangible-Asset was 13.64%. The lowest was 6.25%. And the median was 10.77%.
BDULF's Return-on-Tangible-Asset is ranked better than 84.83% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs BDULF: 11.50
Bangkok Dusit Medical Services PCL (OTCPK:BDULF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Bangkok Dusit Medical Services PCL Return-on-Tangible-Asset Related Terms
Bangkok Dusit Medical Services PCL Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL Return-on-Tangible-Asset Chart
BDULF vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 11.55% mean?
Bangkok Dusit Medical Services PCL (BDULF) has a Return-on-Tangible-Asset of 11.55% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is near median its historical median of 10.77. Over the past decade, Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset has ranged from 6.25 to 13.64. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #103 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 15.2%.
Is Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset too high?
Bangkok Dusit Medical Services PCL's current Return-on-Tangible-Asset of 11.55% is near median its 10-year median of 10.77. Over the past 10 years, this metric has ranged from a low of 6.25 to a high of 13.64. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Bangkok Dusit Medical Services PCL's value of 11.55% is 360.2% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #103 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #103 out of 679 companies for Return-on-Tangible-Asset. This places Bangkok Dusit Medical Services PCL in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.51. Bangkok Dusit Medical Services PCL's value of 11.55% is 360.2% above this benchmark. Historically, Bangkok Dusit Medical Services PCL's own Return-on-Tangible-Asset has ranged from 6.25 to 13.64 over the past decade. While the company's 10-year median is 10.77 vs. the industry median of 2.51, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current Return-on-Tangible-Asset of 11.55% is 360.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current Return-on-Tangible-Asset is 11.55%, which is near median its own 10-year median of 10.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.83, compared to a current price of $0.56 — trading 32.6% below its estimated fair value. The current Return-on-Tangible-Asset is 11.55%, which is near median its 10-year median of 10.77 and 360.2% above the Healthcare Providers & Services industry median of 2.51. Bangkok Dusit Medical Services PCL's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current Return-on-Tangible-Asset is 11.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.56 is trading 32.6% below its estimated GF Value™ of $0.83.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BDULF:
Return-on-Tangible-Asset: 11.55% (near median its 10-year median of 10.77)
GF Value™: $0.83 vs. price of $0.56 (32.6% below fair value)
Industry Position: 360.2% above the Healthcare Providers & Services median (#103 of 679)
No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
68GF Score
Get the complete analysis for BDULF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDULF has been successfully added to your 
